January 09, 2025

curATime is looking for partners!

curATime is looking for partners!
Go back

The curATime cluster is one of 14 pioneering “Clusters4Future” initiatives funded by the German Federal Ministry of Education and Research (BMBF). Its mission is to promote personalized approaches to combat atherothrombosis-related diseases and to establish the Rhine-Main-Palatinate region as an international driver of innovation.

For the planned second implementation phase, the cluster is seeking new partners from science and industry who share its passion for revolutionary research in the field of cardiovascular diseases. It welcomes companies and institutions that can complement its existing expertise in artificial intelligence and mRNA technology and wish to actively contribute to the success of the cluster.

The curATime cluster aims to develop the next generation of medical solutions and revolutionise patient care!
Contact them for more information:

curatime@tron-mainz.de
curATime Cluster – Werden Sie Partner!Download

Our latest News

discover more
BioMed X: Regional Strength for Global Women’s Health

BioMed X: Regional Strength for Global Women’s Health

It is a beacon in the Rhine-Neckar metropolitan region: The Heidelberg-based research company BioMed X is developing new approaches to drug development at the intersection of science and industry – currently, for example, through “XFem Labs,” a women’s health project funded by the Gates Foundation. Full Text in German below. BioMed X: Regionale Power für […]

read more
Strategische Investition in Deutschland: Roche weiht hochmodernes 90-Millionen-Euro-Distributionszentrum in Mannheim ein

Strategische Investition in Deutschland: Roche weiht hochmodernes 90-Millionen-Euro-Distributionszentrum in Mannheim ein

Mannheim, 23. März 2026 Zu den Downloads Mit einer Investition von 90 Millionen Euro stärkt Roche den Standort Mannheim als ein zentrales Drehkreuz im globalen Distributionsnetzwerk für Diagnostika des Unternehmens. Das neue Distributionszentrum für Europa umfasst eine Fläche von rund 16.300 Quadratmetern, das entspricht etwa zweieinhalb Fußballfeldern. Hochmoderne Automatisierungstechnik und nahtlos vernetzte IT- und Transportsysteme […]

read more
InnovationLab GmbH: German Cancer Research Center Expands Its Shareholder Base

InnovationLab GmbH: German Cancer Research Center Expands Its Shareholder Base

Heidelberg, March 18, 2026 – At yesterday’s meeting of the Board of Trustees of the German Cancer Research Center (DKFZ), the board decided to become the fifth shareholder of InnovationLab GmbH (iL). In addition to BASF SE and HEIDELBERG (Heidelberger Druckmaschinen AG), the Karlsruhe Institute of Technology (KIT) and the Ruprecht-Karls University of Heidelberg are […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp